sulpiride has been researched along with Disease Models, Animal in 84 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Specific effects of ultra-low doses of antibodies to prostate-specific antigen obtained from laboratory rats of late reproductive age with sulpiride model of benign prostatic hyperplasia were compared with the results of clinical application of the preparation." | 9.15 | Modification of sulpiride model of benign prostatic hyperplasia for evaluation of the effectiveness of drug therapy. ( Borovskaja, TG; Chemerova, JA; Fomina, TI; Jurmazov, ZA; Pahomova, AV; Poluektova, ME; Rumpel', OA; Sergeeva, SA; Udut, VV, 2011) |
| "The work aimed to develop a co-loaded loratadine and sulpiride nasal nanoemulsion for allergic rhinitis management." | 8.02 | A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis. ( Badawi, AM; Elrehany, M; Maher, SA; Mansour, HF; Mohamad, SA; Safwat, MA, 2021) |
| "Metformin attenuated the visceral allodynia and increased gut permeability in animal IBS models." | 7.91 | Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats. ( Kumei, S; Miyagishi, S; Nozu, R; Nozu, T; Okumura, T; Takakusaki, K, 2019) |
| "The aim of the study was to examine the effects of preferential agonists of dopamine D3 receptors: pramipexole and 7-OH-DPAT on the harmaline-induced tremor in rats (a model of essential tremor, ET)." | 7.83 | Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats. ( Ananthan, S; Głowacka, U; Kosmowska, B; Ossowska, K; Wardas, J, 2016) |
| " We have previously shown altered synaptic plasticity in the hippocampal-NAc pathway in the methylazoxymethanol acetate (MAM) developmental model of schizophrenia in rodents that is dependent on cortical inputs." | 7.79 | Disruption of prefrontal cortical-hippocampal balance in a developmental model of schizophrenia: reversal by sulpiride. ( Belujon, P; Grace, AA; Patton, MH, 2013) |
| "The results indicated that both the histamine and dopamine receptor mechanisms may be involved in the effects of repeated pretreatment of histamine on drug induced amnesia." | 7.76 | Repeated histamine pretreatment decreased amnesia induced by post-training administration of the drug in a step-down inhibitory avoidance test in mice. ( Ahmadi, S; Malekmohammadi, N; Zarrindast, MR, 2010) |
| "We aimed to develop an anovulation model, using sulpiride-induced hyperprolactinemia in common marmosets." | 7.70 | New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline. ( Inada, Y; Kojima, M; Komatsu, H; Miyata, H; Moro, M; Torii, R, 1999) |
| "To assess the role of insulin in the development of obesity induced by antipsychotic drugs, a glucose tolerance test was conducted in 40 female rats during the peak of sulpiride-induced weight gain and in 40 vehicle-treated animals." | 7.70 | Glucose tolerance and serum insulin levels in an animal model of obesity induced by the antipsychotic drug, sulpiride. ( Baptista, T; Hernández, L; LaCruz, A, 1998) |
| "L-sulpiride, at a dose of 4 mg/kg, essentially abolished motion-induced emesis in a group of 6 squirrel monkeys undergoing horizontal rotation at 25 rpm, a terrestrial model of space motion sickness (SMS)." | 7.67 | The anti-emetic properties of 1-sulpiride in a ground-based model of space motion sickness. ( Brizzee, KR; Miller, JD, 1987) |
| "It has been shown that long-term administration of l-sulpiride induces a down-regulation of beta receptor-associated adenylate cyclase activity in the frontal cortex of rats, and adaptive response that is typically associated with the chronic administration of antidepressants." | 5.29 | Chronic administration of l-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of "depression-like" behavior. ( Bertolini, A; Forgione, A; Vergoni, AV, 1995) |
| "Specific effects of ultra-low doses of antibodies to prostate-specific antigen obtained from laboratory rats of late reproductive age with sulpiride model of benign prostatic hyperplasia were compared with the results of clinical application of the preparation." | 5.15 | Modification of sulpiride model of benign prostatic hyperplasia for evaluation of the effectiveness of drug therapy. ( Borovskaja, TG; Chemerova, JA; Fomina, TI; Jurmazov, ZA; Pahomova, AV; Poluektova, ME; Rumpel', OA; Sergeeva, SA; Udut, VV, 2011) |
| "The work aimed to develop a co-loaded loratadine and sulpiride nasal nanoemulsion for allergic rhinitis management." | 4.02 | A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis. ( Badawi, AM; Elrehany, M; Maher, SA; Mansour, HF; Mohamad, SA; Safwat, MA, 2021) |
| "Experimental model of sulpiride-provoked benign prostatic hyperplasia was employed to comparatively assess the effect of phenolic antioxidants (dihydroquercetin, p-thyrozol, dibornol, and prostagenin) on prostate morphology." | 3.91 | Effectiveness of Phenolic Antioxidants in Experimental Model of Benign Prostatic Hyperplasia. ( Borovskaya, TG; Buravlev, EV; Chukicheva, IY; Dygai, AM; Fomina, TI; Goldberg, VE; Grigor'eva, VA; Kamalova, SI; Kuchin, AV; Plotnikov, MB; Poluektova, ME; Vychuzhanina, AV, 2019) |
| "Prostatotropic activity of (3,5-dimethyl-4-hydroxy)benzyl thiododecane (T-DD) was evaluated on a model of benign prostatic hyperplasia induced in Wistar rats by chronic (2 months) intraperitoneal administration of sulpiride (40 mg/kg)." | 3.91 | Morphological Assessment of Prostatotropic Activity of (3,5-Dimethyl-4-Hydroxy)Benzyl Thiododecane on a Model of Benign Prostatic Hyperplasia in Rats. ( Nizomov, SA; Prosenko, AE; Semenov, DE; Sorokina, IV; Tolstikova, TG; Zhukova, NA, 2019) |
| "Metformin attenuated the visceral allodynia and increased gut permeability in animal IBS models." | 3.91 | Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats. ( Kumei, S; Miyagishi, S; Nozu, R; Nozu, T; Okumura, T; Takakusaki, K, 2019) |
| "To test whether sulpiride (SP), an anti-psychotic and prokinetic drug, shows beneficial effects on experimental murine colitis, a colon-targeted prodrug of SP, 5-(aminoethanoylsulfamoyl)-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzamide (glycylsulpiride (GSP)), was synthesized and its colonic delivery and therapeutic activity against 2,4-dinitrobenzenesulfonic acid (DNBS)-induced rat colitis were assessed." | 3.91 | Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery. ( Jeong, S; Jung, Y; Kim, D; Kim, W; Yoo, JW, 2019) |
| "The aim of the study was to examine the effects of preferential agonists of dopamine D3 receptors: pramipexole and 7-OH-DPAT on the harmaline-induced tremor in rats (a model of essential tremor, ET)." | 3.83 | Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats. ( Ananthan, S; Głowacka, U; Kosmowska, B; Ossowska, K; Wardas, J, 2016) |
| " We have previously shown altered synaptic plasticity in the hippocampal-NAc pathway in the methylazoxymethanol acetate (MAM) developmental model of schizophrenia in rodents that is dependent on cortical inputs." | 3.79 | Disruption of prefrontal cortical-hippocampal balance in a developmental model of schizophrenia: reversal by sulpiride. ( Belujon, P; Grace, AA; Patton, MH, 2013) |
| "The results indicated that both the histamine and dopamine receptor mechanisms may be involved in the effects of repeated pretreatment of histamine on drug induced amnesia." | 3.76 | Repeated histamine pretreatment decreased amnesia induced by post-training administration of the drug in a step-down inhibitory avoidance test in mice. ( Ahmadi, S; Malekmohammadi, N; Zarrindast, MR, 2010) |
| "Afala (ultralow-dose antibodies to prostate-specific antigen) injected for 60 days to rats with hormone-induced prostatitis caused by sulpiride prevented the development of prostatic hyperplasia and reduced the severity of histological changes." | 3.74 | Comparative study of pharmacological activity of afala on the model of hormone-induced prostatitis in rats. ( Borovskaya, TG; Dugina, JL; Epstein, OI; Kheyfets, IA; Savelieva, KV; Sergeeva, SA, 2007) |
| " This experiment investigated the role of dopaminergic activity in the inescapable stress-induced learned helplessness, a widely used depression animal model, by using the pharmacological manipulation through the apomorphine (APO), an agonist for D1 and D2 receptors, and sulpiride (SUL), a selective D2 antagonist." | 3.74 | Effects of apomorphine on the expression of learned helplessness behavior. ( Ho, YJ; Hsu, CC; Hsu, WY; Lei, YP; Tseng, T; Wang, CF; Wang, WF, 2007) |
| "Microinjections of glutamic acid, serotonin, and sulpiride in the ventromedial hypothalamus reduced anxiety in an illuminated platform avoidance task in rats, while dopamine, apomorphine, picrotoxin, and memantine increased it." | 3.71 | The role of neurochemical mechanisms of ventromedial hypothalamus in various models of anxiety in rats. ( Gordienko, DV; Krivobok, GK; Pankrat'ev, DV; Talalaenko, AN; Zinkovich, II, 2001) |
| "To assess the role of insulin in the development of obesity induced by antipsychotic drugs, a glucose tolerance test was conducted in 40 female rats during the peak of sulpiride-induced weight gain and in 40 vehicle-treated animals." | 3.70 | Glucose tolerance and serum insulin levels in an animal model of obesity induced by the antipsychotic drug, sulpiride. ( Baptista, T; Hernández, L; LaCruz, A, 1998) |
| "We aimed to develop an anovulation model, using sulpiride-induced hyperprolactinemia in common marmosets." | 3.70 | New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline. ( Inada, Y; Kojima, M; Komatsu, H; Miyata, H; Moro, M; Torii, R, 1999) |
| " To assess the role of insulin in the development of the obesity induced by antipsychotic drugs, a glucose tolerance test was conducted in female rats after 0 or 30 days of sulpiride administration." | 3.70 | Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs. ( Alvarez, L; Baptista, T; de Mendoza, S; Hernández, L; Lacruz, A, 1999) |
| "The effects of substituted benzamides, sulpiride and raclopride on experimental models of depression were studied in male rats after acute or chronic administration in comparison to those of the classical antidepressant, clomipramine." | 3.70 | Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats. ( Arezzi, A; Drago, F; Virzì, A, 2000) |
| "L-sulpiride, at a dose of 4 mg/kg, essentially abolished motion-induced emesis in a group of 6 squirrel monkeys undergoing horizontal rotation at 25 rpm, a terrestrial model of space motion sickness (SMS)." | 3.67 | The anti-emetic properties of 1-sulpiride in a ground-based model of space motion sickness. ( Brizzee, KR; Miller, JD, 1987) |
| "The visceral pain was assessed by electrophysiologically measuring the threshold of abdominal muscle contractions in response to colonic distention." | 1.51 | Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome. ( Miyagishi, S; Nozu, R; Nozu, T; Okumura, T; Takakusaki, K, 2019) |
| "Treatment with sulpiride further probed the pharmacological basis of long-term behavioural changes." | 1.40 | The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD. ( d'Angelo, LS; Day, JO; Dongelmans, ML; Eagle, DM; Mar, AC; Morein-Zamir, S; Noble, CA; Noschang, C; Robbins, TW; Theobald, DE; Urcelay, GP, 2014) |
| "Five haloperidol-treated animals developed mild TD movements, and no TD was observed in the clozapine group." | 1.40 | Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model. ( Blanchet, PJ; Lévesque, D; Mahmoudi, S, 2014) |
| "When sulpiride was applied prior to LFS of the vSub after acute stress, there was a pronounced decrease in vSub-evoked responses similar to control animals." | 1.39 | Differential effects of acute and repeated stress on hippocampus and amygdala inputs to the nucleus accumbens shell. ( Gill, KM; Grace, AA, 2013) |
| "Risperidone has been used in some stress disorders and may be potentially protective against stress-induced gastric lesions." | 1.37 | Gastroprotective potential of risperidone, an atypical antipsychotic, against stress and pyloric ligation induced gastric lesions. ( Krishnamurthy, S; Saxena, B; Singh, S, 2011) |
| "The objective of this study was to investigate the effects of chronic administration of a semi-purified extract (Purified Extract A--PEA; 4, 8, or 16 mg/kg) of PAULLINIA CUPANA (guaraná) seeds on rats submitted to the elevated T-maze (ETM) model of generalized anxiety and panic disorders." | 1.37 | Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test. ( Audi, EA; Biesdorf de Almeida, C; de Mello, JC; Klein, T; Roncon, CM, 2011) |
| "Carvacrol (cvc) was administered orally at single doses of 12." | 1.37 | Antidepressant-like effect of carvacrol (5-Isopropyl-2-methylphenol) in mice: involvement of dopaminergic system. ( de Sousa, DP; de Sousa, FC; de Vasconcelos, SM; Fonteles, MM; Macedo, DS; Melo, FH; Moura, BA; Viana, GS, 2011) |
| "Levodopa has been shown to produce analgesia in various clinical and experimental settings, but its use for chronic pain treatment has not been established." | 1.36 | Levodopa analgesia in experimental neuropathic pain. ( Cobacho, N; De la Calle, JL; González-Escalada, JR; Paíno, CL, 2010) |
| "Antipsychotic treatment during pregnancy is indicated when risk of drug exposure to the fetus is outweighed by the untreated psychosis in the mother." | 1.35 | Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats. ( Hao, Y; Liu, H; Liu, Z; Lu, XH; Ouyang, X; Xu, L; Zuo, J, 2008) |
| "This alteration causes involuntary movements in the chorea-ballism spectrum." | 1.33 | Deficits of glutamate transmission in the striatum of experimental hemiballism. ( Baunez, C; Bernardi, G; Calabresi, P; Centonze, D; De Chiara, V; Gubellini, P; Picconi, B; Prosperetti, C; Rossi, S; Tscherter, A, 2006) |
| "Methylphenidate treatment (3 mg/kg daily for 14 days) did not normalize the decreased electrically-stimulated release of [(3)H]dopamine from SHR caudate-putamen slices nor did it affect postsynaptic D(2) receptor function." | 1.31 | Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat. ( de Villiers, AS; Lamm, MC; Russell, VA; Sagvolden, T; Taljaard, JJ, 2000) |
| "Pretreatment with diazepam (0." | 1.31 | Anxiogenic-like effects limit rewarding effects of cocaine in balb/cbyj mice. ( Cazala, P; David, V; Gold, LH; Koob, GF, 2001) |
| " Thus, the inhibitory dose-response effects of a D2-preferring [sulpride], a D3-preferring [U 99194A] and combination of varying doses of these antagonists [sulpride + U 99194A] were evaluated on the ability of the cited agonists to produce vomiting." | 1.30 | The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew). ( Ahmad, B; Darmani, NA; Zhao, W, 1999) |
| "It has been shown that long-term administration of l-sulpiride induces a down-regulation of beta receptor-associated adenylate cyclase activity in the frontal cortex of rats, and adaptive response that is typically associated with the chronic administration of antidepressants." | 1.29 | Chronic administration of l-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of "depression-like" behavior. ( Bertolini, A; Forgione, A; Vergoni, AV, 1995) |
| "Catalepsy was observed in the rat following intrastriatal injections of the dopamine antagonists sulpiride or fluphenazine and after subcutaneous administration of fluphenazine." | 1.28 | Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents. ( Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (9.52) | 18.7374 |
| 1990's | 15 (17.86) | 18.2507 |
| 2000's | 16 (19.05) | 29.6817 |
| 2010's | 36 (42.86) | 24.3611 |
| 2020's | 9 (10.71) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Zarrindast, MR | 3 |
| Fazli-Tabaei, S | 1 |
| Khakpai, F | 1 |
| Noursadeghi, E | 1 |
| Rashvand, M | 2 |
| Haghparast, A | 5 |
| Abdi Dezfouli, R | 1 |
| Ghanbari Merdasi, P | 1 |
| Mousavi, Z | 2 |
| Yin, N | 1 |
| Wang, HN | 1 |
| Ding, WW | 1 |
| Zhou, H | 1 |
| Li, SY | 1 |
| Miao, Y | 1 |
| Li, F | 1 |
| Lei, B | 1 |
| Wang, Z | 1 |
| Borovskaya, TG | 2 |
| Kamalova, SI | 1 |
| Grigor'eva, VA | 1 |
| Poluektova, ME | 2 |
| Vychuzhanina, AV | 1 |
| Kuchin, AV | 1 |
| Chukicheva, IY | 1 |
| Buravlev, EV | 1 |
| Fomina, TI | 2 |
| Plotnikov, MB | 1 |
| Goldberg, VE | 1 |
| Dygai, AM | 1 |
| Nizomov, SA | 1 |
| Sorokina, IV | 1 |
| Zhukova, NA | 1 |
| Tolstikova, TG | 1 |
| Semenov, DE | 1 |
| Prosenko, AE | 1 |
| Nozu, T | 2 |
| Miyagishi, S | 2 |
| Nozu, R | 2 |
| Takakusaki, K | 2 |
| Okumura, T | 2 |
| Tsvetkov, IS | 1 |
| Kosyreva, AM | 1 |
| Mkhitarov, VA | 1 |
| Postovalova, EA | 1 |
| Khochanskiy, DN | 1 |
| Makarova, OV | 1 |
| Bredova, OY | 1 |
| Ostrov, VF | 1 |
| Zhang, N | 1 |
| Luo, M | 1 |
| He, L | 1 |
| Yao, L | 1 |
| Mohamad, SA | 1 |
| Safwat, MA | 1 |
| Elrehany, M | 1 |
| Maher, SA | 1 |
| Badawi, AM | 1 |
| Mansour, HF | 1 |
| Mozafari, R | 1 |
| Karimi-Haghighi, S | 2 |
| Hooshmandi, E | 1 |
| Ghasemi, R | 1 |
| Koruji, M | 1 |
| Ahadi, R | 1 |
| Chen, M | 1 |
| Hoshino, H | 1 |
| Saito, S | 1 |
| Yang, Y | 1 |
| Obata, H | 1 |
| Farzinpour, Z | 1 |
| Kumei, S | 1 |
| Cáceres-Chávez, VA | 1 |
| Hernández-Martínez, R | 1 |
| Pérez-Ortega, J | 1 |
| Herrera-Valdez, MA | 1 |
| Aceves, JJ | 1 |
| Galarraga, E | 1 |
| Bargas, J | 1 |
| Kim, D | 2 |
| Kim, W | 1 |
| Jeong, S | 1 |
| Yoo, JW | 1 |
| Jung, Y | 1 |
| Vetlugina, TP | 1 |
| Lobacheva, OA | 1 |
| Al'perina, EL | 1 |
| Zhukova, EN | 1 |
| Semke, AV | 1 |
| Nikitina, VB | 1 |
| Cheĭdo, MA | 1 |
| Idova, GV | 1 |
| Nikiforuk, A | 2 |
| Popik, P | 2 |
| Gill, KM | 1 |
| Grace, AA | 2 |
| Eagle, DM | 1 |
| Noschang, C | 1 |
| d'Angelo, LS | 1 |
| Noble, CA | 1 |
| Day, JO | 1 |
| Dongelmans, ML | 1 |
| Theobald, DE | 1 |
| Mar, AC | 1 |
| Urcelay, GP | 1 |
| Morein-Zamir, S | 1 |
| Robbins, TW | 1 |
| Mahmoudi, S | 1 |
| Lévesque, D | 1 |
| Blanchet, PJ | 1 |
| Pendolino, V | 1 |
| Bagetta, V | 1 |
| Ghiglieri, V | 1 |
| Sgobio, C | 1 |
| Morelli, E | 1 |
| Poggini, S | 1 |
| Branchi, I | 1 |
| Latagliata, EC | 1 |
| Pascucci, T | 1 |
| Puglisi-Allegra, S | 1 |
| Calabresi, P | 2 |
| Picconi, B | 2 |
| Huang, F | 1 |
| Yan, T | 1 |
| Shi, F | 1 |
| An, J | 1 |
| Xie, R | 1 |
| Zheng, F | 1 |
| Li, Y | 1 |
| Chen, J | 1 |
| Qu, J | 2 |
| Zhou, X | 2 |
| Jiang, L | 1 |
| Long, K | 1 |
| Schaeffel, F | 1 |
| Zheng, Y | 1 |
| Ying, H | 1 |
| Lu, F | 1 |
| Stell, WK | 1 |
| Hołuj, M | 1 |
| Lesovaya, EA | 1 |
| Kirsanov, KI | 1 |
| Antoshina, EE | 1 |
| Trukhanova, LS | 1 |
| Gorkova, TG | 1 |
| Shipaeva, EV | 1 |
| Salimov, RM | 1 |
| Belitsky, GA | 1 |
| Blagosklonny, MV | 1 |
| Yakubovskaya, MG | 1 |
| Chernova, OB | 1 |
| Klenotich, SJ | 1 |
| Ho, EV | 1 |
| McMurray, MS | 1 |
| Server, CH | 1 |
| Dulawa, SC | 1 |
| Kosmowska, B | 1 |
| Wardas, J | 1 |
| Głowacka, U | 1 |
| Ananthan, S | 1 |
| Ossowska, K | 1 |
| Jensen, R | 1 |
| Charmchi, E | 1 |
| Zendehdel, M | 1 |
| Nasehi, M | 1 |
| Mafi, F | 1 |
| Ebrahimi-Ghiri, M | 1 |
| Sasaki-Hamada, S | 1 |
| Suzuki, A | 1 |
| Ueda, Y | 1 |
| Matsumoto, K | 1 |
| Oka, JI | 1 |
| Savelieva, KV | 1 |
| Kheyfets, IA | 1 |
| Dugina, JL | 1 |
| Sergeeva, SA | 2 |
| Epstein, OI | 1 |
| Lukács, A | 1 |
| Szabó, A | 1 |
| Papp, A | 1 |
| Vezér, T | 1 |
| Ahmadi, S | 1 |
| Malekmohammadi, N | 1 |
| Melo, FH | 1 |
| Moura, BA | 1 |
| de Sousa, DP | 1 |
| de Vasconcelos, SM | 1 |
| Macedo, DS | 1 |
| Fonteles, MM | 1 |
| Viana, GS | 1 |
| de Sousa, FC | 1 |
| Cobacho, N | 1 |
| De la Calle, JL | 1 |
| González-Escalada, JR | 1 |
| Paíno, CL | 1 |
| Roncon, CM | 1 |
| Biesdorf de Almeida, C | 1 |
| Klein, T | 1 |
| de Mello, JC | 1 |
| Audi, EA | 1 |
| Yi, LT | 1 |
| Xu, HL | 1 |
| Feng, J | 1 |
| Zhan, X | 1 |
| Zhou, LP | 1 |
| Cui, CC | 1 |
| Saxena, B | 1 |
| Krishnamurthy, S | 1 |
| Singh, S | 1 |
| Savio, LE | 1 |
| Vuaden, FC | 1 |
| Piato, AL | 1 |
| Bonan, CD | 1 |
| Wyse, AT | 1 |
| Borovskaja, TG | 1 |
| Udut, VV | 1 |
| Jurmazov, ZA | 1 |
| Pahomova, AV | 1 |
| Chemerova, JA | 1 |
| Rumpel', OA | 1 |
| Barchini, J | 1 |
| Tchachaghian, S | 1 |
| Shamaa, F | 1 |
| Jabbur, SJ | 1 |
| Meyerson, BA | 1 |
| Song, Z | 1 |
| Linderoth, B | 1 |
| Saadé, NE | 1 |
| Taylor, GT | 1 |
| Smith, SE | 1 |
| Kirchhoff, BA | 1 |
| Belujon, P | 1 |
| Patton, MH | 1 |
| Talalaenko, AN | 2 |
| Pankrat'ev, DV | 2 |
| Goncharenko, NV | 1 |
| Sugiyama, A | 1 |
| Rinaldi, A | 1 |
| Mandillo, S | 1 |
| Oliverio, A | 1 |
| Mele, A | 1 |
| Centonze, D | 1 |
| Rossi, S | 1 |
| Gubellini, P | 1 |
| De Chiara, V | 1 |
| Tscherter, A | 1 |
| Prosperetti, C | 1 |
| Bernardi, G | 1 |
| Baunez, C | 1 |
| Wang, WF | 1 |
| Lei, YP | 1 |
| Tseng, T | 1 |
| Hsu, WY | 1 |
| Wang, CF | 1 |
| Hsu, CC | 1 |
| Ho, YJ | 1 |
| Zuo, J | 1 |
| Liu, Z | 1 |
| Ouyang, X | 1 |
| Liu, H | 1 |
| Hao, Y | 1 |
| Xu, L | 1 |
| Lu, XH | 1 |
| Hajnal, A | 1 |
| Margas, WM | 1 |
| Covasa, M | 1 |
| Offermeier, J | 1 |
| van Rooyen, JM | 1 |
| Morgenstern, R | 1 |
| Fink, H | 1 |
| Oelssner, W | 1 |
| Advis, JP | 1 |
| Richards, JS | 1 |
| Ojeda, SR | 1 |
| Bárány, S | 1 |
| Häggström, JE | 1 |
| Gunne, LM | 1 |
| Prinssen, EP | 1 |
| Ellenbroek, BA | 1 |
| Stamatovic, B | 1 |
| Cools, AR | 1 |
| Akai, T | 1 |
| Ozawa, M | 1 |
| Yamaguchi, M | 1 |
| Mizuta, E | 1 |
| Kuno, S | 1 |
| Parada, MA | 1 |
| de Parada, MP | 1 |
| Rada, P | 1 |
| Hernandez, L | 3 |
| Vergoni, AV | 1 |
| Forgione, A | 1 |
| Bertolini, A | 1 |
| George, B | 1 |
| Kulkarni, SK | 1 |
| Levivier, M | 1 |
| Przedborski, S | 1 |
| Murer, MG | 1 |
| Dziewczapolski, G | 1 |
| Menalled, LB | 1 |
| García, MC | 1 |
| Agid, Y | 1 |
| Gershanik, O | 1 |
| Raisman-Vozari, R | 1 |
| Baptista, T | 2 |
| LaCruz, A | 2 |
| Moro, M | 1 |
| Inada, Y | 1 |
| Kojima, M | 1 |
| Miyata, H | 1 |
| Komatsu, H | 1 |
| Torii, R | 1 |
| Alvarez, L | 1 |
| de Mendoza, S | 1 |
| Darmani, NA | 1 |
| Zhao, W | 1 |
| Ahmad, B | 1 |
| Jackson, DM | 1 |
| Simpson, WT | 1 |
| Papp, M | 1 |
| Wieronska, J | 1 |
| Russell, VA | 1 |
| de Villiers, AS | 1 |
| Sagvolden, T | 1 |
| Lamm, MC | 1 |
| Taljaard, JJ | 1 |
| Drago, F | 1 |
| Arezzi, A | 1 |
| Virzì, A | 1 |
| David, V | 1 |
| Gold, LH | 1 |
| Koob, GF | 1 |
| Cazala, P | 1 |
| Gordienko, DV | 1 |
| Zinkovich, II | 1 |
| Krivobok, GK | 1 |
| Takamori, K | 1 |
| Yoshida, S | 1 |
| Okuyama, S | 1 |
| la Barre, J | 1 |
| Sampson, D | 1 |
| Willner, P | 1 |
| Muscat, R | 1 |
| Elliott, PJ | 2 |
| Close, SP | 2 |
| Walsh, DM | 2 |
| Hayes, AG | 2 |
| Marriott, AS | 2 |
| Feldon, J | 1 |
| Weiner, I | 1 |
| Carnoy, P | 1 |
| Soubrie, P | 1 |
| Puech, AJ | 1 |
| Simon, P | 1 |
| Horie, K | 1 |
| Ban, C | 1 |
| Taii, S | 1 |
| Mori, T | 1 |
| Aso, T | 1 |
| Miller, JD | 1 |
| Brizzee, KR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics[NCT03430596] | Early Phase 1 | 50 participants (Actual) | Interventional | 2018-05-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for sulpiride and Disease Models, Animal
| Article | Year |
|---|---|
[Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models].
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Antitubercular Agents; Cat | 2003 |
1 trial available for sulpiride and Disease Models, Animal
| Article | Year |
|---|---|
Modification of sulpiride model of benign prostatic hyperplasia for evaluation of the effectiveness of drug therapy.
Topics: Animals; Antibodies; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Male; Middle | 2011 |
82 other studies available for sulpiride and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Synergistic effect between quinpirole and L-NAME as well as sulpiride and L-arginine on the modulation of anxiety and memory processes in the 6-OHDA mouse model of Parkinson's disease: An isobologram analysis.
Topics: Adrenergic Agents; Animals; Anxiety; Arginine; Disease Models, Animal; Dopamine Agonists; Dopamine A | 2021 |
Nucleus accumbens dopamine receptors mediate the stress-induced analgesia in an animal model of acute pain.
Topics: Acute Pain; Analgesia; Animals; Benzazepines; Disease Models, Animal; Dopamine Antagonists; Male; Nu | 2022 |
The modulatory role of dopamine receptors within the hippocampal cornu ammonis area 1 in stress-induced analgesia in an animal model of persistent inflammatory pain.
Topics: Analgesia; Animals; Benzazepines; Dimethyl Sulfoxide; Disease Models, Animal; Dopamine Antagonists; | 2022 |
Dopamine receptor-mediated roles on retinal ganglion cell hyperexcitability and injury in experimental glaucoma.
Topics: Animals; Disease Models, Animal; Glaucoma; Ocular Hypertension; Rats; Rats, Sprague-Dawley; Receptor | 2023 |
Effectiveness of Phenolic Antioxidants in Experimental Model of Benign Prostatic Hyperplasia.
Topics: Acinar Cells; Animals; Animals, Outbred Strains; Anti-Inflammatory Agents; Antioxidants; Disease Mod | 2019 |
Morphological Assessment of Prostatotropic Activity of (3,5-Dimethyl-4-Hydroxy)Benzyl Thiododecane on a Model of Benign Prostatic Hyperplasia in Rats.
Topics: Animals; Disease Models, Animal; Down-Regulation; Male; Organ Size; Plant Extracts; Prostate; Prosta | 2019 |
Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
Topics: Animals; Butyrates; Colon; Disease Models, Animal; Electrodes; Hyperalgesia; Inflammation; Irritable | 2019 |
Morphological and Biochemical Characteristics of Prostate Hyperplasia during Sulpiride Treatment.
Topics: Acinar Cells; Animals; Disease Models, Animal; Dopamine Antagonists; Epithelial Cells; Gene Expressi | 2020 |
Chemical Composition of Essential Oil from Flower of 'Shanzhizi' (
Topics: Administration, Inhalation; Animals; Anti-Anxiety Agents; Biogenic Monoamines; Cyclohexanes; Disease | 2020 |
A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis.
Topics: Administration, Intranasal; Animals; Calorimetry, Differential Scanning; Disease Models, Animal; Dop | 2021 |
Hippocampal D1-but not D2-like dopamine receptors modulate the phosphorylation of ERK in food deprivation-induced reinstatement of morphine in extinguished rats.
Topics: Analgesics, Opioid; Animals; Benzazepines; Dentate Gyrus; Disease Models, Animal; Dopamine Antagonis | 2021 |
Spinal dopaminergic involvement in the antihyperalgesic effect of antidepressants in a rat model of neuropathic pain.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Cyclopropanes; Disease Models, Animal; Do | 2017 |
Antagonism of the D1- and D2-like dopamine receptors in the nucleus accumbens attenuates forced swim stress- and morphine priming-induced reinstatement of extinguished rats.
Topics: Animals; Benzazepines; Conditioning, Psychological; Disease Models, Animal; Dopamine Antagonists; Do | 2018 |
Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.
Topics: AMP-Activated Protein Kinases; Animals; Colon; Disease Models, Animal; Domperidone; Dopamine Antagon | 2019 |
Acute dopamine receptor blockade in substantia nigra pars reticulata: a possible model for drug-induced Parkinsonism.
Topics: Action Potentials; Animals; Benzazepines; Disease Models, Animal; Dopamine Antagonists; Dopaminergic | 2018 |
Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery.
Topics: Animals; Benzamides; Colitis; Colon; Dinitrofluorobenzene; Disease Models, Animal; Dose-Response Rel | 2019 |
[Clinical and experimental research of immunomodulatory effect of amisulpride].
Topics: Adult; Amisulpride; Animals; Antibodies, Anti-Idiotypic; Antipsychotic Agents; Disease Models, Anima | 2012 |
Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Attention; Cognition Disorders; Disease Models, Animal; | 2013 |
Differential effects of acute and repeated stress on hippocampus and amygdala inputs to the nucleus accumbens shell.
Topics: Amygdala; Animals; Behavior, Animal; Disease Models, Animal; Dopamine Antagonists; Electric Stimulat | 2013 |
The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD.
Topics: Animals; Anxiety; Compulsive Behavior; Conditioning, Operant; Disease Models, Animal; Dopamine Agoni | 2014 |
Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.
Topics: Animals; Antipsychotic Agents; Brain; Cebus; Clozapine; Disease Models, Animal; Dopamine Antagonists | 2014 |
l-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via β-adrenergic receptors.
Topics: Animals; Antiparkinson Agents; Benzazepines; Dentate Gyrus; Disease Models, Animal; Dopamine; Dopami | 2014 |
Activation of dopamine D2 receptor is critical for the development of form-deprivation myopia in the C57BL/6 mouse.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Dopamine Antagonists; Form Perception; Mice; | 2014 |
Effects of dopaminergic agents on progression of naturally occurring myopia in albino guinea pigs (Cavia porcellus).
Topics: Animals; Apomorphine; Benzazepines; Disease Models, Animal; Disease Progression; Dopamine Agonists; | 2014 |
Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Excitatory Ami | 2015 |
Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Disease Models, Animal; Drug Administration Schedule; F | 2015 |
Dopamine D2/3 receptor antagonism reduces activity-based anorexia.
Topics: Amisulpride; Animals; Anorexia Nervosa; Benzodiazepines; Disease Models, Animal; Dopamine D2 Recepto | 2015 |
Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats.
Topics: Amisulpride; Animals; Anti-Dyskinesia Agents; Benzothiazoles; Disease Models, Animal; Dopamine Agoni | 2016 |
Effects of Dopamine D2-Like Receptor Antagonists on Light Responses of Ganglion Cells in Wild-Type and P23H Rat Retinas.
Topics: Action Potentials; Animals; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Light; Pyridin | 2015 |
The effect of forced swim stress on morphine sensitization: Involvement of D1/D2-like dopamine receptors within the nucleus accumbens.
Topics: Animals; Benzazepines; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Dose-Response Relat | 2016 |
Function of opioidergic and dopaminergic antagonists on both spatial and object novelty detection deficits induced in rodent model of hepatic encephalopathy.
Topics: Animals; Benzazepines; Disease Models, Animal; Dopamine Antagonists; Exploratory Behavior; Hepatic E | 2016 |
Serotonergic and dopaminergic systems are implicated in antidepressant-like effects of chotosan, a Kampo formula, in mice.
Topics: Animals; Antidepressive Agents; Disease Models, Animal; Dopamine Agents; Drugs, Chinese Herbal; Fenc | 2017 |
Comparative study of pharmacological activity of afala on the model of hormone-induced prostatitis in rats.
Topics: Animals; Antibodies; Disease Models, Animal; Immunoenzyme Techniques; Male; Organ Size; Plant Extrac | 2007 |
Altered open field behavior in rats induced by acute administration of 3-nitropropionic acid: possible glutamatergic and dopaminergic involvement.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Dopamine D2 | 2009 |
Repeated histamine pretreatment decreased amnesia induced by post-training administration of the drug in a step-down inhibitory avoidance test in mice.
Topics: Amnesia; Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Benzazepines; Disease | 2010 |
Antidepressant-like effect of carvacrol (5-Isopropyl-2-methylphenol) in mice: involvement of dopaminergic system.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepre | 2011 |
Levodopa analgesia in experimental neuropathic pain.
Topics: Analgesics; Animals; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; | 2010 |
Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Disease Models, Animal; Dopamine Agents; Es | 2011 |
Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin.
Topics: Adrenergic Antagonists; Animals; Antidepressive Agents; Benzazepines; Cyproheptadine; Depression; Di | 2011 |
Gastroprotective potential of risperidone, an atypical antipsychotic, against stress and pyloric ligation induced gastric lesions.
Topics: Animals; Antipsychotic Agents; Capillary Permeability; Dinoprostone; Disease Models, Animal; Dopamin | 2011 |
Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish.
Topics: 1-Pyrroline-5-Carboxylate Dehydrogenase; Amino Acid Metabolism, Inborn Errors; Animals; Antipsychoti | 2012 |
Spinal segmental and supraspinal mechanisms underlying the pain-relieving effects of spinal cord stimulation: an experimental study in a rat model of neuropathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Baclofen; | 2012 |
Differential effects of antipsychotics on lateral bias and social attention in female rats.
Topics: Animals; Antipsychotic Agents; Attention; Behavior, Animal; Clozapine; Disease Models, Animal; Femal | 2013 |
Disruption of prefrontal cortical-hippocampal balance in a developmental model of schizophrenia: reversal by sulpiride.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Female; Hippocampus; Long-Term Potentiation; | 2013 |
Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti- | 2003 |
D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice.
Topics: Afferent Pathways; Animals; Benzazepines; Disease Models, Animal; Dopamine; Dopamine Antagonists; Do | 2007 |
Deficits of glutamate transmission in the striatum of experimental hemiballism.
Topics: Anesthetics, Local; Animals; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Dyskines | 2006 |
Effects of apomorphine on the expression of learned helplessness behavior.
Topics: Adaptation, Psychological; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Depression; D | 2007 |
Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Brain; Conditioning, Psychological; Di | 2008 |
Altered dopamine D2 receptor function and binding in obese OLETF rat.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Conditioning, Operant; Disease Models, Anima | 2008 |
Dopamine inhibitory and excitatory systems in tardive dyskinesias.
Topics: Animals; Apomorphine; Disease Models, Animal; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced | 1983 |
LSD-potentiated apomorphine hypermotility: a model for differentiating antipsychotic drugs.
Topics: Animals; Apomorphine; Chlorpromazine; Clozapine; Disease Models, Animal; Drug Antagonism; Haloperido | 1983 |
Hyperprolactinemia-induced precocious puberty: studies on the mechanism(s) by which prolactin enhances ovarian progesterone responsiveness to gonadotropins in prepubertal rats.
Topics: Animals; Chorionic Gonadotropin; Disease Models, Animal; Estradiol; Female; Follicle Stimulating Hor | 1981 |
Application of a primate model for tardive dyskinesia.
Topics: Animals; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Histamine An | 1983 |
Role of striatal dopamine D2 receptors in the paw test, an animal model for the therapeutic efficacy and extrapyramidal side effects of neuroleptic drugs.
Topics: Animals; Antipsychotic Agents; Corpus Striatum; Disease Models, Animal; Dopamine D2 Receptor Antagon | 1995 |
Behavioral involvement of central dopamine D1 and D2 receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned parkinsonian cynomolgus monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Behavior, Animal; Disease Models | 1995 |
Sulpiride increases and dopamine decreases intracranial temperature in rats when injected in the lateral hypothalamus: an animal model for the neuroleptic malignant syndrome?
Topics: Animals; Body Temperature; Brain; Disease Models, Animal; Dopamine; Fever; Hypothalamic Area, Latera | 1995 |
Chronic administration of l-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of "depression-like" behavior.
Topics: Animals; Behavior, Animal; Depression; Disease Models, Animal; Female; Male; Mice; Motor Activity; R | 1995 |
Dopaminergic modulation of lithium/pilocarpine-induced status epilepticus in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Azepines; Benzazepines; Disease | 1997 |
Quinolinic acid-induced lesions of the rat striatum: quantitative autoradiographic binding assessment.
Topics: Animals; Autoradiography; Benzazepines; Binding, Competitive; Cholinergic Agents; Corpus Striatum; D | 1998 |
Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Carrier Proteins; Disease | 1998 |
Glucose tolerance and serum insulin levels in an animal model of obesity induced by the antipsychotic drug, sulpiride.
Topics: Animals; Antipsychotic Agents; Area Under Curve; Blood Glucose; Disease Models, Animal; Eating; Estr | 1998 |
New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline.
Topics: Animals; Anovulation; Bromocriptine; Cabergoline; Callithrix; Disease Models, Animal; Dopamine Agoni | 1999 |
Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Female; Glucose Tolerance Test; Hyperinsulini | 1999 |
The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew).
Topics: Analysis of Variance; Animals; Apomorphine; Benzopyrans; Brain Chemistry; Disease Models, Animal; Do | 1999 |
The effect of dopamine on the rapidly adapting receptors in the dog lung.
Topics: Adrenergic beta-Agonists; Airway Resistance; Animals; Asthma; Chemoreceptor Cells; Disease Models, A | 2000 |
Antidepressant-like activity of amisulpride in two animal models of depression.
Topics: Amisulpride; Animals; Antidepressive Agents; Antipsychotic Agents; Depression; Disease Models, Anima | 2000 |
Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat.
Topics: Acetylcholine; Animals; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopam | 2000 |
Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats.
Topics: Animals; Antidepressive Agents; Benzamides; Clomipramine; Depression; Disease Models, Animal; Dose-R | 2000 |
Anxiogenic-like effects limit rewarding effects of cocaine in balb/cbyj mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Caudate Nucleus; Cocaine; Conditioning, Operant; Diaze | 2001 |
The role of neurochemical mechanisms of ventromedial hypothalamus in various models of anxiety in rats.
Topics: Adrenergic Agents; Animals; Anxiety; Apomorphine; Avoidance Learning; Disease Models, Animal; Dopami | 2001 |
Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Benzazep | 2001 |
[Sulpiride treatment of the withdrawal syndrome in heroin-addicted dogs].
Topics: Animals; Disease Models, Animal; Dogs; Heroin Dependence; Humans; Substance Withdrawal Syndrome; Sul | 1975 |
Reversal of antidepressant action by dopamine antagonists in an animal model of depression.
Topics: Animals; Antidepressive Agents, Tricyclic; Benzazepines; Depressive Disorder; Disease Models, Animal | 1991 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationsh | 1990 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Fluphenazine; | 1990 |
The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.
Topics: Animals; Appetitive Behavior; Arousal; Association Learning; Attention; Brain; Conditioning, Classic | 1991 |
Performance deficit induced by low doses of dopamine agonists in rats. Toward a model for approaching the neurobiology of negative schizophrenic symptomatology?
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Male; Phenothiazine | 1986 |
Impaired steroidogenic function of corpora lutea from hyperprolactinemic baboons induced by sulpiride.
Topics: Animals; Corpus Luteum; Disease Models, Animal; Estradiol; Female; Follicle Stimulating Hormone; Hyp | 1986 |
The anti-emetic properties of 1-sulpiride in a ground-based model of space motion sickness.
Topics: Animals; Antiemetics; Chlorpromazine; Disease Models, Animal; Domperidone; Female; Male; Motion Sick | 1987 |